Evidence map›Paper›PMID 41551727›Full record

ArticleNAR molecular medicine2026

eVGeMdb: a manually curated database for experimentally validated genetic modifiers of neurodegenerative disorders.

Subashani Singh, Pratibha Singh, M P Varada, M J Vijaivasudev, Rahul Kumar, Indranil Malik

Abstract read
In one paragraph

Article in NAR molecular medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Subashani SinghDepartment of Biotechnology, Indian Institute of Technology Hyderabad, Kandi, Telangana 502284, India.ORCID https://orcid.org/0000-0002-4117-5400
Pratibha SinghDepartment of Biotechnology, Indian Institute of Technology Hyderabad, Kandi, Telangana 502284, India.ORCID https://orcid.org/0009-0009-6260-6570
M P VaradaDepartment of Biotechnology, Indian Institute of Technology Hyderabad, Kandi, Telangana 502284, India.
M J VijaivasudevDepartment of Biotechnology, Indian Institute of Technology Hyderabad, Kandi, Telangana 502284, India.
Rahul KumarDepartment of Biotechnology, Indian Institute of Technology Hyderabad, Kandi, Telangana 502284, India.ORCID https://orcid.org/0000-0002-6927-5390
Indranil MalikDepartment of Biotechnology, Indian Institute of Technology Hyderabad, Kandi, Telangana 502284, India.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Genetic modifiers are genes that, while not directly causing disease, can alter the onset, progression, severity, or specific phenotypes of a disease by interacting with the primary disease-causing genes. Despite their importance, knowledge of these modifiers remains fragmented across different experimental models of neurodegenerative disorders (NDs). To address this lacuna, we developed eVGeMdb (https://project.iith.ac.in/cgntlab/eVGeMdb/), a manually curated, comprehensive database of experimentally validated genetic modifiers of major NDs, including Amyotrophic Lateral Sclerosis, Alzheimer's disease, Parkinson's disease, Huntington's disease, Spinocerebellar ataxias, Fragile X-associated Tremor/Ataxia Syndrome, and other general PolyQ disorders. eVGeMdb integrates modifiers from commonly used diverse experimental model systems, including

Identifiers

PMID41551727
PMCPMC12805892

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.